Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is one of the best small cap stocks to buy for 10x potential. On May 4, Stifel ...

The stock market saw gains on May 15, with Sensex rising 451.46 points and Nifty 50 up 143.25 points, led by IT stocks. Oil ...

On January 14, Reuters reported that investors foresee a comeback in the US biotech sector in 2026, with more IPO activity ...

Novo Nordisk and Biogen are underpriced and stand to gain from new indications for their blockbuster therapies.

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) reported first-quarter revenue of $2.71 million on May 6, compared with analyst ...

It's no longer a secret that the Teva Pharmaceutical Industries (NYSE: TEVA) of the past is no more. The Israel-based company ...

Top 10 mid-cap stocks by YTD performance amid market volatility—see 600%+ gainers across semis, biotech & more, plus mid-cap ...

Learn more TG Therapeutics Inc (NASDAQ:TGTX) is trading down 1.2% at $42.35, after last week being rejected by the overhead ...

A few years ago, Pfizer (PFE +0.51%) looked unstoppable. The company generated more than $100 billion in annual revenue early ...

Top picks include a consensus buy on NMDC, alongside Zydus Lifesciences, Varun Beverages (VBL), Max Healthcare, and Tata ...

The Indian stock market ended Friday's session on a higher note. Sumeet Bagadia of Choice Broking recommends five breakout ...

ICICI Direct maintained a 'Buy' rating with a target price of Rs 5,750. The firm highlighted that revenues grew, driven by established power brands such as Eliquis, Magnex, and Meronem.